Aldeyra Therapeutics, Inc. (ALDX)
5.62
+0.16
(+2.93%)
USD |
NASDAQ |
Mar 02, 16:00
5.54
-0.08
(-1.42%)
After-Hours: 20:00
Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.1074 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| MediciNova, Inc. | -0.057 |
| Altimmune, Inc. | -0.2126 |
| AbbVie, Inc. | 1.018 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.462M |
| Total Expenses (Quarterly) | 6.462M |
| Enterprise Value | 283.60M |
| Earnings Yield | -10.03% |
| Normalized Earnings Yield | -10.03 |